Earnings Feed
Start Free
Allogene Therapeutics, Inc.·4

Jan 14, 2:13 PM ET

Kazam Joshua A 4

4 · Allogene Therapeutics, Inc. · Filed Jan 14, 2022

Insider Transaction Report

Form 4
Period: 2022-01-12
Allogene Therapeutics, Inc.ALLO
Kazam Joshua A
Director
Transactions
  • Purchase

    Common Stock

    2022-01-12$12.60/sh+15,000$189,000→ 258,885 total

Documents

1 file
  • 4
    marketforms-55053.xmlPrimary

    PRIMARY DOCUMENT